Amid Higher Interest Rates, Alaska Air Group, Inc. (ALK) Looks to Refinance Pandemic Loans; Settles $1 Billion Lawsuit
An aerial view of a cargo plane taking off from a commercial airport, reflecting the company's overnight air cargo services.
On July 17, 2025, Bloomberg reported that Alaska Air Group, Inc. (NYSE:ALK) is looking to refinance its $689 million worth of loans that it took out from the U.S. state during the pandemic in 2020 and 2021. The company borrowed the funds to support employee payroll amid an industry-wide downturn.
Alaska Air Group, Inc.'s (NYSE:ALK) refinancing plan is tied to interest rates on the loan, which increase after five years of issuance to incentivize the borrower to at least find refinancing alternatives, if not repay. As such, the interest rate, which originally stood at flat 1%, will increase 2% over the Secured Overnight Financing Rate (SOFR), reaching 6%. The fact that ALK carries junk ratings from each of the three major bond rating agencies will be crucial as it continues its efforts to ease post-pandemic recovery and navigate a higher interest rate environment.
Meanwhile, Alaska Air Group, Inc. (NYSE:ALK) has reached an out-of-court settlement on a $1 billion lawsuit. The lawsuit relates to the mid-flight door blowout incident, leaving passengers terrified. The details of the settlement, which reportedly took place on July 7, haven't been disclosed yet.
Alaska Air Group, Inc. (NYSE:ALK), an air carrier, operates through three segments: Alaska Airlines, Hawaiian Airlines, and Regional. It is on the list of cheap transportation stocks.
While we acknowledge the potential of ALK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Billionaire Kerr Neilson's 10 Stock Picks with Huge Upside Potential and .
Disclosure: None.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Novo Lifer Takes Job of Reviving Europe's Weight-Loss Superstar
(Bloomberg) — Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through logistics and marketing roles to head of international operations. Now the relatively unknown insider is moving into the spotlight with a daunting task: revive a once high-flying drugmaker from a steep descent that's wiped out two-thirds of its value in the past year. Budapest's Most Historic Site Gets a Controversial Rebuild San Francisco in Talks With Vanderbilt for Downtown Campus The World's Data Center Capital Has Residents Surrounded An Abandoned Art-Deco Landmark in Buffalo Awaits Revival Trump Administration Sues NYC Over Sanctuary City Policy Doustdar has pledged to work quickly, and there were hints on Tuesday that part of his response may involve cutbacks and job reductions. He said he would look at 'realigning the cost base,' though he didn't offer any details. Doustdar's appointment as Novo's new chief executive officer was announced alongside a stark reminder of the challenges ahead, particularly in the US, the biggest market for obesity treatments. The Danish firm, based just north of Copenhagen, cut its earnings outlook as its blockbuster weight-loss drug Wegovy continues to cede ground to archrival Eli Lilly & Co., whose competing treatment has gained momentum in the US market and beyond. The 54-year-old inherits a global powerhouse facing a critical point after being beset with supply shortfalls, drug pipeline failures and sharp competition that's shaken investor confidence in its prospects. Questions have already emerged on whether Doustdar — who has helmed Novo's non-US operations in recent years — is the right leader, given the company's headwinds are particularly linked to the US. He pushed back against any doubts on a call on Tuesday, defending his track record. The US is 'more than half of our business and we don't just sit there running our own area, but we support the CEO,' he said. 'So I've sat in this executive management team for more than 10 years and I know enough of the US business.' The past year has marked a sharp reversal of fortune for Novo, which became a household name for jump-starting the booming obesity drug market with its GLP-1 medicines. But it's failed to keep up with runaway demand and misjudged the speed and scale of competition, including a shadow market of copycat compounds. Mixed trial data and heightened political scrutiny over pricing have further shaken investor confidence. The stock's slump from its June 2024 peak has erased more than $400 billion from Novo, dethroning it as Europe's most valuable company. That ultimately cost its former CEO, Lars Fruergaard Jorgensen, his job in May. After the cut to the outlook, the shares fell almost 30% at one point on Tuesday. They closed down 23%, the biggest one-day drop on record. 'I don't like it,' Doustdar said of the share-price moves. He added that 'setbacks don't define companies. Our response does.' Novo is also hugely important to Denmark. The company has doubled its headcount over the past decade to more than 77,000 people, and just under a half of them work in its home country. In many ways, the drugmaker's influence in Denmark is outsized: for a time last year, its market value topped the size of the economy, its tax bill helps fund the government's increased defense spending and booming drug exports have forced the central bank to keep interest rates low. On Tuesday, Novo Chair Helge Lund described Doustdar as a 'natural challenger,' saying he 'has a bias for speed, for pace and for action.' The new CEO is an Austrian national, who was born in Iran and raised in the US. He joined Novo in 1992 in Vienna. He ran with the idea of speed when speaking to investors on Tuesday. 'We will sharpen our focus and move faster,' Doustdar said. 'We will operate more efficiently. We will advance our pipeline and keep pushing the boundaries of innovation, and we will invest to accelerate growth and deliver shareholder value. That is my promise to you.' —With assistance from Lisa Pham and Christian Wienberg. Burning Man Is Burning Through Cash It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan Cage-Free Eggs Are Booming in the US, Despite Cost and Trump's Efforts Everyone Loves to Hate Wind Power. Scotland Found a Way to Make It Pay Off Elon Musk's Empire Is Creaking Under the Strain of Elon Musk ©2025 Bloomberg L.P.


The Verge
11 minutes ago
- The Verge
An in-depth profile of Luke Farritor, 23-year-old IT Renfield.
Posted Jul 29, 2025 at 5:34 PM UTC An in-depth profile of Luke Farritor, 23-year-old IT Renfield. 'Luke's résumé didn't pass muster,' says one former government official, but obviously that doesn't matter to DOGE. Farritor is 'designated a GS-15, the highest salary rank for civilians, earning $167,603,' Bloomberg reports. He's chauffeured around in a black SUV. And he's betting that even if DOGE is a failure, he's written his ticket for life: 'To gamble like that shows you understand the theater of Silicon Valley.' DOGE-Pilled [ Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates. Elizabeth Lopatto Posts from this topic will be added to your daily email digest and your homepage feed. See All AI Posts from this topic will be added to your daily email digest and your homepage feed. See All Elon Musk Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy Posts from this topic will be added to your daily email digest and your homepage feed. See All Politics Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech


Bloomberg
41 minutes ago
- Bloomberg
Spotify Swings to a Second-Quarter Loss
- Spotify Technology SA swung to a loss in the second quarter, missing analysts' estimates after the music-streaming service recorded higher-than-expected expenses related to employee compensation. Earnings dropped to a loss of 42 euro cents per share, the company said in a statement Tuesday, missing analysts projections for a profit of €1.97. Revenue increased about 10% to €4.19 billion ($4.8 billion), compared with Wall Street estimates of €4.27 billion. The Stockholm-based company also gave a forecast for the current quarter that was weaker than analysts had expected. Spotify's shares tumbled as much as 11% to on Tuesday in New York to $626, the biggest intraday decline since April 4. The stock had gained 57% this year through Monday, boosted by efforts to reduce costs, which led the company to its first full year of profit in 2024. Bloomberg Geetha Ranganathan reports. (Source: Bloomberg)